The company expired its plan on July 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.16 CNY | +5.72% | +9.98% | +3.12% |
Feb. 29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Feb. 28 | Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.12% | 1.59B | |
+1.69% | 12.95B | |
-7.57% | 7.84B | |
+3.22% | 5.5B | |
+0.93% | 4.61B | |
+8.48% | 4.61B | |
+9.21% | 2.66B | |
-13.87% | 2.08B | |
-11.63% | 1.72B | |
+3.45% | 1.79B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Sansure Biotech Inc.'s Equity Buyback announced on March 18, 2022, has expired with 2,942,813 shares, representing 0.5% for CNY 119.97 million.